Indegene Ltd
INDGNBSE 544172Healthcare Research, Analytics & TechnologyMkt cap ₹14,313 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹1,063 Cr
YoY +39.7%QoQ +5.9%
Net profit · Q1 FY27
₹116 Cr
YoY -0.2%QoQ +45.8%
Net margin · Q1 FY27
10.9%
-4.4 pts vs Q1 FY26
Net profit · FY26
₹401 Cr
YoY -1.4%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,003 | 942 | 804 | 761 | +39.7% |
| Other income | 29.00 | 10.80 | 19.40 | 19.70 | 22.10 | +31.2% |
| Total income | 1,092 | 1,014 | 962 | 824 | 783 | +39.5% |
| Profit before tax | 153 | 105 | 135 | 133 | 152 | +0.4% |
| Tax | 36.50 | 25.40 | 31.80 | 31.00 | 35.70 | +2.2% |
| Net profit | 116 | 79.70 | 103 | 102 | 116 | -0.2% |
| Net margin | 10.9% | 7.9% | 10.9% | 12.7% | 15.3% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | YoY |
|---|---|---|---|---|
| Revenue | 3,511 | 2,839 | 2,590 | +23.6% |
| Other income | 72.00 | 107 | 76.30 | -32.8% |
| Total income | 3,583 | 2,947 | 2,666 | +21.6% |
| Profit before tax | 525 | 539 | 459 | -2.7% |
| Tax | 124 | 133 | 122 | -6.6% |
| Net profit | 401 | 407 | 337 | -1.4% |
| Net margin | 11.4% | 14.3% | 13.0% |
BIC's take
We haven't covered Indegene Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 5:14 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.